跳至主要内容
临床试验/EUCTR2007-006252-19-AT
EUCTR2007-006252-19-AT进行中(未招募)1 期

Einfluss von peroraler Methylprednisolon-Gabe auf die postoperative Morbidität nach operativer Weisheitszahnenfernung im Unterkiefer.(Influence of peroral Methylprednisolone administration on the postsurgical morbidity after surgical removal of lower third molars.)

niv.-Prof. DDr. Norbert Jakse, Universitätszahnklinik Graz, Dep. f. Orale Chirurgie u. Röntgenologi0 个研究点目标入组 16 人开始时间: 2008年7月8日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • +male and female healthy patients between the age of 18 and 40
  • +lower third molars which have to be removed surgically
  • +impacted lower third molars
  • +axis: vertical or mesial tilted
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -preagnancy and lactation
  • -patients with an affection of the Temporo-mandibular joint
  • -presurgical inflammation or pain in the area of the lower third molars
  • -diseases which are a contraindication for the use of one of the drugs to be taken
  • -incompatibility to one of the drugs to be taken or lactose
  • -severe diseases which are a contraindication to a surgical removal of third molars
  • -current participation in other pharmacological studies
  • -when a complicated removal of the lower third molar can be anticipated because of its position in the jaw

研究者

发起方
niv.-Prof. DDr. Norbert Jakse, Universitätszahnklinik Graz, Dep. f. Orale Chirurgie u. Röntgenologi

相似试验